These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24846270)

  • 1. Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
    Fliedner SM; Engel T; Lendvai NK; Shankavaram U; Nölting S; Wesley R; Elkahloun AG; Ungefroren H; Oldoerp A; Lampert G; Lehnert H; Timmers H; Pacak K
    PLoS One; 2014; 9(5):e97712. PubMed ID: 24846270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warburg effect's manifestation in aggressive pheochromocytomas and paragangliomas: insights from a mouse cell model applied to human tumor tissue.
    Fliedner SM; Kaludercic N; Jiang XS; Hansikova H; Hajkova Z; Sladkova J; Limpuangthip A; Backlund PS; Wesley R; Martiniova L; Jochmanova I; Lendvai NK; Breza J; Yergey AL; Paolocci N; Tischler AS; Zeman J; Porter FD; Lehnert H; Pacak K
    PLoS One; 2012; 7(7):e40949. PubMed ID: 22859959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: focus on SDHB tumors.
    Matro J; Giubellino A; Pacak K
    Horm Metab Res; 2013 Feb; 45(2):147-53. PubMed ID: 23322515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.
    Lendvai N; Pawlosky R; Bullova P; Eisenhofer G; Patocs A; Veech RL; Pacak K
    Endocrinology; 2014 Jan; 155(1):27-32. PubMed ID: 24189137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.
    Pang Y; Yang C; Schovanek J; Wang H; Bullova P; Caisova V; Gupta G; Wolf KI; Semenza GL; Zhuang Z; Pacak K
    Oncotarget; 2017 Apr; 8(14):22313-22324. PubMed ID: 28423608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pheochromocytoma blockade of MAPK pathway inhibition in the NF-κB pathway and bFGF - effect of statins on pheochromocytoma patients.
    Hu HJ; Zhou SH; Liu QM
    Int J Cardiol; 2015 Mar; 182():161-2. PubMed ID: 25577776
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
    Shankavaram U; Fliedner SM; Elkahloun AG; Barb JJ; Munson PJ; Huynh TT; Matro JC; Turkova H; Linehan WM; Timmers HJ; Tischler AS; Powers JF; de Krijger R; Baysal BE; Takacova M; Pastorekova S; Gius D; Lehnert H; Camphausen K; Pacak K
    Neoplasia; 2013 Apr; 15(4):435-47. PubMed ID: 23555188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models.
    Bullova P; Cougnoux A; Abunimer L; Kopacek J; Pastorekova S; Pacak K
    Oncotarget; 2016 Jun; 7(26):40531-40545. PubMed ID: 27244895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells.
    Richter S; D'Antongiovanni V; Martinelli S; Bechmann N; Riverso M; Poitz DM; Pacak K; Eisenhofer G; Mannelli M; Rapizzi E
    Cell Tissue Res; 2018 Dec; 374(3):473-485. PubMed ID: 30159755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib Alone and in Combination With Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death In Vitro and in Female Nude Mice.
    Bullova P; Cougnoux A; Marzouca G; Kopacek J; Pacak K
    Endocrinology; 2017 Oct; 158(10):3097-3108. PubMed ID: 28938421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.
    Nölting S; Giubellino A; Tayem Y; Young K; Lauseker M; Bullova P; Schovanek J; Anver M; Fliedner S; Korbonits M; Göke B; Vlotides G; Grossman A; Pacak K
    Endocrinology; 2014 Jul; 155(7):2377-90. PubMed ID: 24762141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway.
    Zhang X; Zhong S
    Anticancer Agents Med Chem; 2020; 20(7):828-833. PubMed ID: 32188393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of atorvastatin in suppressing MUC5AC gene expression in human airway epithelial cells.
    Lee EJ; Song KJ; Hwang HJ; Kim KS
    Int Forum Allergy Rhinol; 2016 Nov; 6(11):1159-1166. PubMed ID: 27310028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel liquid biopsy (NETest) identifies paragangliomas and pheochromocytomas with high accuracy.
    Pacak K; Kidd M; Meuter L; Modlin IM
    Endocr Relat Cancer; 2021 Oct; 28(11):731-744. PubMed ID: 34515661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable somatostatin receptor subtype expression in 151 primary pheochromocytomas and paragangliomas.
    Leijon H; Remes S; Hagström J; Louhimo J; Mäenpää H; Schalin-Jäntti C; Miettinen M; Haglund C; Arola J
    Hum Pathol; 2019 Apr; 86():66-75. PubMed ID: 30529752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microenvironment induces collective migration in
    D'Antongiovanni V; Martinelli S; Richter S; Canu L; Guasti D; Mello T; Romagnoli P; Pacak K; Eisenhofer G; Mannelli M; Rapizzi E
    Endocr Relat Cancer; 2017 Oct; 24(10):555-564. PubMed ID: 28830936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
    Sivaprasad U; Abbas T; Dutta A
    Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas.
    Elston MS; Meyer-Rochow GY; Conaglen HM; Clarkson A; Clifton-Bligh RJ; Conaglen JV; Gill AJ
    Hum Pathol; 2015 Mar; 46(3):390-6. PubMed ID: 25554089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.
    Xekouki P; Brennand A; Whitelaw B; Pacak K; Stratakis CA
    Horm Metab Res; 2019 Jul; 51(7):419-436. PubMed ID: 30273935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.